KindlyMD, Inc. (NASDAQ:NAKA) Stock Has Average Price Target of $20.00 According to Brokerages

Shares of KindlyMD, Inc. (NASDAQ:NAKA) have been assigned an average rating of “Hold” from the five research firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $20.00.

NAKA has been the topic of a number of research analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of KindlyMD in a report on Friday, August 7th. B. Riley Financial upped their price objective on shares of KindlyMD from $11.00 to $13.00 and gave the stock a “buy” rating in a report on Tuesday, September 22nd. Finally, TD Cowen raised their target price on shares of KindlyMD from $1.00 to $17.00 and gave the company a “buy” rating in a research note on Monday, July 27th.

Insiders Place Their Bets

In other KindlyMD news, CEO David F. Bailey bought 32,134 shares of the company’s stock in a transaction dated Wednesday, August 19th. The shares were bought at an average price of $5.59 per share, for a total transaction of $179,629.06. Following the acquisition, the chief executive officer directly owned 32,134 shares of the company’s stock, valued at approximately $179,629.06. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last 90 days, insiders bought 41,904 shares of company stock worth $235,231. Insiders own 24.49% of the company’s stock.

Hedge Funds Weigh In On KindlyMD

Several large investors have recently made changes to their positions in the business. Hunting Hill Global Capital LLC acquired a new stake in KindlyMD in the 4th quarter valued at approximately $4,672,000. Yorkville Advisors Global LP acquired a new position in shares of KindlyMD during the fourth quarter worth approximately $3,265,000. Arrington Capital Management LLC bought a new stake in shares of KindlyMD in the fourth quarter valued at approximately $1,028,000. Waddell & Associates LLC bought a new stake in shares of KindlyMD in the fourth quarter valued at approximately $201,000. Finally, J. Derek Lewis & Associates Inc. acquired a new stake in shares of KindlyMD in the fourth quarter worth $167,000.

KindlyMD Price Performance

NASDAQ NAKA opened at $9.57 on Friday. KindlyMD has a 1-year low of $3.33 and a 1-year high of $42.80. The firm has a market capitalization of $171.26 million, a P/E ratio of -0.27 and a beta of 15.82. The business’s 50-day simple moving average is $7.33 and its 200-day simple moving average is $6.71.

KindlyMD (NASDAQ:NAKA) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($6.65) earnings per share for the quarter. The company had revenue of $35.87 million for the quarter. KindlyMD had a negative return on equity of 63.45% and a negative net margin of 1,067.93%. On average, equities research analysts expect that KindlyMD will post -12.94 EPS for the current fiscal year.

KindlyMD Company Profile

KindlyMD is a healthcare company focused on providing integrated, patient-centered medical services. Its care model is designed to address physical and behavioral health needs in a coordinated setting, with an emphasis on chronic pain management, mental health, and substance-use treatment.

The company’s services include primary care, behavioral health support, treatment for opioid-use disorder and other addiction-related conditions, and care programs for patients dealing with chronic pain.